- Home
- Therapeutische gebieden
- Dermatologie
- Oncologie
- Pulmonologie
- Reumatologie
- Hematologie
- Hematalks
- Congressen
- ASH 2019
- A Test to Quantify NOTCH Pathway Activity in T Cell Acute Lymphoblastic Leukemia Patients
- ASH 2019 - Minimal Residual Disease and IKZF1 As Predictors of Relapse, and Increased Treatment Related Mortality in Down Syndrome Acute Lymphoblastic Leukemia: A Unique and Large International Matched Case-Control Study
- ASH 2019 - Novel Thermostable Inhibitor of Contact Activation Tica Effectively Blocks Contact Activation in Low Tissue Factor Thrombin Generation
- ASH 2019 - Proteomic Landscape of Acute Leukemia: A Comparison between ALL and AML in Adults
- ASH 2019 - Proton Pump Inhibition for Secondary Hemochromatosis in Hereditary Anemia, a Phase III Placebo Controlled Randomized Cross-over Trial in progress
- ASH 2019 Highlight: Myelodysplastisch Syndroom
- ASH 2019: Highlight: acute lymfatische leukemie kinderen
- Adding Azathioprine and Hydroxyurea Preconditioning to Alemtuzumab/TBI May Improve Donor Chimerism in Matched Sibling Donor Allogeneic Stem Cell Transplantation in Adult Sickle Cell Patients
- Association of Endothelial Biomarkers with Cerebral MRI Perfusion Analysis in Patients with Sickle Cell Disease
- Baseline Metabolic Tumor Volume in 18FDG-PET-CT Scans in Classical Hodgkin Lymphoma Using Semi-Automatic Segmentation
- Complications of Extra Fluid Therapy (Hyperhydration) in Sickle Cell Patients during Vaso-Occlusive Painful Crisis
- Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors
- Efficacy and Safety of Nivolumab Combined with Daratumumab with or without Low-Dose Cyclophosphamide in Relapsed/Refractory Multiple Myeloma; Interim Analysis of the Phase 2 Nivo-Dara Study
- Hemolysis in the Spleen Drives Erythrocyte Turnover
- Higher Expression of Nuclear Cereblon in Bone Marrow Biopsies of Patients with Multiple Myeloma Treated with Imids in the HOVON-87/Nmsg-18 Trial Is Associated with Longer PFS and OS
- Inflammatory Bone Marrow Microenvironment
- Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses
- MAPK-ERK Pathway Activation: The Achilles’ Heel of IL-7R‒Induced Steroid Resistance
- Minimal Residual Disease and Stem Cell Transplantation OutcomesMinimal Residual Disease and Stem Cell Transplantation Outcomes
- One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Receiving Prior Eculizumab Treatment
- Platelet CD34 Expression and a Congenital Collar Bone Malformation Associated with a Partial CBFB Deletion in a Case with a Bleeding Disorder
- Role of Disease Modifying Treatment in the Risk of Alloimmunization in Transfused Patients with Myelodysplastic Syndromes: A Population-Based Study
- The First Functional HLA-a*01:01-Restricted EBV-LMP2-Specific T-Cell Receptors for TCR Gene Therapy of Patients with EBV-Associated Type II/III Malignancies
- The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: An Individual Patient Data Meta-Analysis By the Petra Consortium
- Untargeted Metabolomics on Dried Blood Spots for the Diagnosis and Clinical Follow up of Rare Hereditary Anemias
- Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients Receiving Vincristine through Push Injections or One-Hour Infusions: Results of a Randomized Clinical Trial
- ASH 2018
- ASH 2017
- ASH archief
- EHA 2019
- 'Patient perceptions on splenectomy outcomes: results from the ITP World Impact Survey (I-WISH)’
- Arianne Brandsma
- Cansu Koyunla
- Coagulation, hematopoiesis and tumorigenesis
- Dr. Anita Rijneveld (video)
- Dr. Elly Lugtenburg
- Dr. Marieke Griffioen
- Dr. Marije Bartels (video)
- Dr. Mirian Brink
- Dr. Peter Valk (video)
- Dr. Peter Westerweel
- Dr. Peter de Keizer
- Drs. Bas Haak
- Drs. Emile van den Akker
- Drs. Eva Koster
- Drs. Floor Heubel-Moenen
- Drs. Hidde Posthuma
- Drs. Hélène Gleitz
- Drs. Julia Driessen (video)
- Drs. Kyra Fuchs
- Drs. Maaike van Bergen
- Drs. Marije de Rooij
- Drs. Mathilde de Jong
- Drs. Myra Langendonk
- Drs. Ruben Bierings
- Drs. Yannouck van Lier
- EHA 2019 - Dr. Marije Bartels
- EHA 2019 - Drs. Julia Driessen
- EHA 2019 - Fibrosis driving myofibroblast precursors in MPN & new therapeutic pathways
- EHA 2019 - Prof. dr. Daphne de Jong
- EHA 2019 - Tisagenlecleucel (Kymriah)
- EHA-ESMO Joint Symposium: Magnitude of Clinical Benefit Scale (MCBS)
- Impact of the new EU regulations for in Vitro Diagnostics (IVDR)
- Is it of vital importance to identify BCR-ABL-like ALL?
- Molecular minimal residual disease detection in acute myeloid leukemia
- Prof. Dr. A. van de Loosdrecht
- Prof. Dr. Christa Cobbaert (video)
- Prof. Dr. J. van Dongen
- Prof. Dr. Pieter Reitsma (video)
- Prof. Dr. Pieter Sonneveld (video)
- Prof. dr. Arnon Kater
- Prof. dr. Daphne de Jong (video)
- Prof. dr. Jacques van Dongen
- Prof. dr. Pieter Sonneveld
- Rowan Kuiper
- Tisagenlecleucel appears effective and safe in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia with high-risk cytogenetic abnormalities
- EHA 2018
- EHA 2017
- EHA archief
- Nationaal Congres
- International Congress Other
- ASH
- ASH 2019
- Indicatiegebieden
- Congressen
- Hematalks
- Neurologie
- Migraine
- Multiple Sclerose (MS)
- De gezichten van MS
- ECTRIMS 2018
- Nascholingen MS
- Online CME
- De vage lijn tussen RRMS en SPMS: kunnen nieuwe tools de SPMS-diagnose in focus brengen?
- Gebruik van biomarkers in MS: initiëren met de juiste therapie in de klinische praktijk
- Pediatrische multiple sclerose: het begin van een nieuw tijdperk?
- Secundaire progressieve multiple sclerose: wat weten we en waar gaan we naartoe?
- Online CME
- Studies
- Oogheelkunde
- Producten
- Nascholingen & Events
- Webshop
- Contact
×
Ask Speakers
×